Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation.
Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation.
复制标题
DOI:
10.3389/fcvm.2022.893681
复制
发表时间:
2022
影响因子:
3.6
通讯作者:
Boutjdir, Mohamed
中科院分区:
文献类型:
--
作者:
Lazzerini, Pietro Enea;Accioli, Riccardo;Acampa, Maurizio;Zhang, Wen-Hui;Verrengia, Decoroso;Cartocci, Alessandra;Bacarelli, Maria Romana;Xin, Xiaofeng;Salvini, Viola;Chen, Ke-Su;Salvadori, Fabio;D'errico, Antonio;Bisogno, Stefania;Cevenini, Gabriele;Marzotti, Tommaso;Capecchi, Matteo;Laghi-Pasini, Franco;Chen, Long;Capecchi, Pier Leopoldo;Boutjdir, Mohamed
关键词:
Heart rate-corrected QT interval (QTc) prolongation is prevalent in patients with severe coronavirus disease 2019 (COVID-19) and is associated with poor outcomes. Recent evidence suggests that the exaggerated host immune-inflammatory response characterizing the disease, specifically interleukin-6 (IL-6) increase, may have an important role, possibly via direct effects on cardiac electrophysiology. The aim of this study was to dissect the short-term discrete impact of IL-6 elevation on QTc in patients with severe COVID-19 infection and explore the underlying mechanisms. We investigated the following mechanisms: (1) the QTc duration in patients with COVID-19 during the active phase and recovery, and its association with C-reactive protein (CRP) and IL-6 levels; (2) the acute impact of IL-6 administration on QTc in an in vivo guinea pig model; and (3) the electrophysiological effects of IL-6 on ventricular myocytes in vitro. In patients with active severe COVID-19 and elevated IL-6 levels, regardless of acute myocardial injury/strain and concomitant QT-prolonging risk factors, QTc was significantly prolonged and rapidly normalized in correlation with IL-6 decrease. The direct administration of IL-6 in an in vivo guinea pig model acutely prolongs QTc duration. Moreover, ventricular myocytes incubated in vitro with IL-6 show evident prolongation in the action potential, along with significant inhibition in the rapid delayed rectifier potassium current (IKr). For the first time, we demonstrated that in severe COVID-19, systemic inflammatory activation can per se promote QTc prolongation via IL-6 elevation, leading to ventricular electric remodeling. Despite being transitory, such modifications may significantly contribute to arrhythmic events and associated poor outcomes in COVID-19. These findings provide a further rationale for current anti-inflammatory treatments for COVID-19, including IL-6-targeted therapies.
登录
查看更多内容
DOI:
10.1007/s10840-021-01033-8
发表时间:
2022-03
期刊:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
影响因子:
--
作者:
Gulletta S;Della Bella P;Pannone L;Falasconi G;Cianfanelli L;Altizio S;Cinel E;Da Prat V;Napolano A;D'Angelo G;Brugliera L;Agricola E;Landoni G;Tresoldi M;Rovere PQ;Ciceri F;Zangrillo A;Vergara P
通讯作者:
Vergara P
影响因子:
5.7
作者:
Lazzerini, Pietro Enea;Laghi-Pasini, Franco;Capecchi, Pier Leopoldo
通讯作者:
Capecchi, Pier Leopoldo
影响因子:
2
作者:
Alsagaff MY;Oktaviono YH;Dharmadjati BB;Lefi A;Al-Farabi MJ;Gandi P;Marsudi BA;Azmi Y
通讯作者:
Azmi Y
影响因子:
2.8
作者:
Elsaid, Ossama;McCullough, Peter A.;Yoon, Anthony
通讯作者:
Yoon, Anthony
影响因子:
3.8
作者:
Hamlin, RL;Kijtawornrat, A;Hamlin, DM
通讯作者:
Hamlin, DM